Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Constitutive meeting of Biohit Oyj’s Board of Directors | ||
By: Nasdaq / GlobeNewswire - 25 Apr 2019 | Back to overview list |
|
Biohit Oyj: Other information disclosed according to the rules of the Exchange April 25, 2019 at 9:30 am local time (EEST) Biohit Oyj’s Board of Directors has in its meeting yesterday elected Mr Osmo Suovaniemi as the Chairman of the Board of Directors. Additional information: CEO Semi Korpela, Biohit Oyj Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |